美国镭学会局部晚期直肠癌选择性盆腔放疗适用标准执行摘要:共识声明
美国镭学会多学科委员会采用PICOTS框架、Cochrane与PRISMA方法学及RAND-UCLA改良Delphi法,系统评价2005年1月1日至2025年6月24日发表的前瞻性与回顾性(n≥50)研究,最终纳入35篇文献,形成局部晚期直肠癌选择性使用盆腔放疗的适用性共识推荐,并提供治疗流程以辅助临床决策。
要点
- 共识针对局部晚期直肠癌切除后低至中度局部区域复发风险患者,评估选择性省略盆腔放疗的适用性。
- 推荐基于RAND-UCLA改良Delphi共识方法分级,证据来自35篇文献,含14项设计良好研究。
- 委员会提供变异病例示例与治疗流程,辅助判断何时可安全省略放疗。
核心结论
- 共识就局部晚期直肠癌患者选择性使用盆腔放疗形成适用性推荐,并给出治疗流程以辅助治疗决策。
研究设计与样本
- 多学科委员会(胃肠放疗与肿瘤内科、消化内科、放射科、结直肠外科)采用PICOTS框架、Cochrane与PRISMA方法学检索Embase、Medline和PubMed(2005年1月1日至2025年6月24日),纳入前瞻性与回顾性(n≥50)研究,用RAND-UCLA改良Delphi法评定适用性。
诊断标准与关键数值
- 检索策略识别110篇文献,35篇符合全部纳入标准被选为证据,其中治疗性研究35篇:设计良好研究14项(II期随机与III期)、中等设计研究12项(匹配队列与II期)、设计有局限的回顾性综述7项、Meta分析3项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pelvic radiotherapy is commonly incorporated in the treatment of locally-advanced rectal cancer to reduce the risk of locoregional recurrence, but can be associated with substantial acute toxicity and long-term morbidity. However, treatment may be personalized for selective use of radiotherapy in a subset of patients identified to be at low to intermediate risk of locoregional recurrence following resection. This multi-specialty-led committee included gastrointestinal radiation and medical oncology, gastroenterology, radiology, and colorectal surgery. Using the Population, Intervention, Comparator, Outcome, Timing and Study Design (PICOTS) framework, evidence regarding treatment outcomes was assessed using Cochrane and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. Eligible studies included prospective and retrospective (n ≥ 50) studies published between 1/1/2005 - 6/24/2025 from Embase, Medline and PubMed databases. Study type and quality were assessed. Well-established RAND corportaion/University of California Los Angeles (RAND-UCLA) consensus methodology (modified Delphi) was used to rate the appropriateness of the treatment options. Of the 110 articles identified using the search strategy, 35 were selected that met all inclusion criteria. Of the 35 references used as evidence, 35 are categorized as therapeutic including 14 well-designed studies (Phase II randomized and Phase III), 12 moderately well-designed studies that account for most common biases (matched cohort and Phase II studies), 7 studies with design limitations (retrospective reviews), and 3 meta-analyses. Variant cases were developed as examples to illustrate practical applications of consensus recommendations for when RT can be safely omitted. A treatment algorithm is also provided to assist with treatment decisions when considering selective use of pelvic RT.
引用
- Tchelebi LT, Jethwa KR, Dozios E, et al. Executive Summary of the American Radium Society Appropriate Use Criteria for Selective Use of Pelvic Radiation Therapy in Locally Advanced Rectal Cancer: A Consensus Statement. Int J Radiat Oncol Biol Phys. 2026. PMID: 41895479. doi:10.1016/j.ijrobp.2026.03.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。